
Ultragenyx Pharmaceutical Inc (0LIF)
LSE
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -58.589 | -32.655 | -43.419 | -12.889 | -27.668 | -46.118 | -39.957 | -38.016 |
Return on Equity (%) | -70.476 | -39.826 | -63.79 | -20.636 | -43.721 | -110.963 | -193.225 | -214.498 |
Return on Invested Capital (%) | -77.704 | -73.718 | -69.585 | -34.388 | -33.593 | -64.74 | -57.653 | -58.663 |
Operating Margin (%) | -12187.519 | -382.75 | -384.046 | -56.107 | -120.533 | -181.298 | -124.919 | -90.06 |
Net Profit Margin (%) | -11567.343 | -383.748 | -388.305 | -68.836 | -129.202 | -194.705 | -139.698 | -101.598 |
Book Value Per Share | 4.472 | 8.558 | 8.305 | 14.649 | 10.778 | 2.108 | 0.788 | 0.429 |
Earnings Per Share | -6.841 | -3.885 | -6.963 | -2.792 | -6.547 | -10.078 | -7.388 | -6.164 |
Cash Per Share | 2.275 | 2.23 | 7.497 | 10.678 | 4.436 | 1.894 | 2.601 | 1.881 |
Working Capital Per Share | 4.496 | 8.801 | 12.928 | 16.548 | 9.737 | 8.871 | 5.501 | 5.122 |
Operating Profit Per Share | 0.059 | 0.99 | 1.637 | 3.964 | 4.837 | 4.818 | 4.784 | 5.621 |
EBIT Per Share | -7.208 | -3.875 | -6.906 | -2.774 | -6.532 | -9.997 | -7.41 | -6.146 |
EBITDA Per Share | -7.208 | -3.875 | -6.906 | -2.774 | -6.532 | -9.997 | -7.41 | -6.146 |
Free Cash Flow Per Share | -6.909 | -4.189 | -6.681 | -2.319 | -5.684 | -8.256 | -7.135 | -6.333 |
Fin d'année 31 Décembre 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 44,17M | 50,86M | 57,84M | 66,82M | 69,35M | 70,2M | N/A | N/A |
Capitalisation boursière | 5,98B |
Ratio cours/bénéfice | -6,96 |
Ratio prix/ventes | 7,07 |
Ratio prix/liquidités | 22,8 |
Ratio prix/valeur comptable | 15,1 |
Rendement de dividende | - |
Actions en circulation | 92,34M |
Volume moyen (1 semaine) | 71 |
Volume moyen (1 mois) | 243 |
Variation sur 52 semaines | 0,00% |
Plus haut sur 52 semaines | 64,79 |
Plus bas sur 52 semaines | 64,79 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales